Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,472
datasets available to search
ShareScore release 0.9.0
Dataset results
1,472 results for “EGFR”
A Phase II, Single-Arm Trial of Poziotinib as Salvage Treatment in Patients With Metastatic Breast Cancer Who Has HER2 or EGFR Mutation or Activated AR or EGFR Pathway
ClinicalTrials.gov study NCT02544997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression
ClinicalTrials.gov study NCT06269211. IPD Sharing: NO. Countries: 1. Publications: 0.
In Vivo EGFR-ECD Molecular Imaging Using [68Ga]- Labelling Anti-EGFR Affibody Molecule
ClinicalTrials.gov study NCT02916329. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
EGFR806-specific CAR T Cell Locoregional Immunotherapy for EGFR-positive Recurrent or Refractory Pediatric CNS Tumors
ClinicalTrials.gov study NCT03638167. IPD Sharing: NO. Countries: 1. Publications: 0.
Neoadjuvant Osimertinib + Chemotherapy for EGFR-mutant Stage III NSCLC
ClinicalTrials.gov study NCT05011487. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Trial of Amivantamab Plus Monochemotherapy in Platinum Unfit NSCLC Patients With EGFR exon20 Insertion Mutations.
ClinicalTrials.gov study NCT07392658. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
ClinicalTrials.gov study NCT01391260. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RC108 Combine With Furmonertinib With/Without Toripalimab in Patients With EGFR-mutated NSCLC
ClinicalTrials.gov study NCT05821933. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Afatinib in Lung Cancer With EGFR Mutation From Circulating Tumor DNA
ClinicalTrials.gov study NCT02629523. IPD Sharing: NO. Countries: 1. Publications: 0.
First-line Treatment With Osimertinib in EGFR-mutated Non-small Cell Lung Cancer
ClinicalTrials.gov study NCT03804580. IPD Sharing: UNDECIDED. Countries: 4. Publications: 0.
DZD9008 In Combination With Bevacizumab in Locally Advanced or Metastatic NSCLC Patients With EGFR Mutation (WU-KONG29)
ClinicalTrials.gov study NCT06276283. IPD Sharing: NO. Countries: 1. Publications: 0.
PDX Models From EGFR Mutant Tumors
ClinicalTrials.gov study NCT03872440. IPD Sharing: NO. Countries: 1. Publications: 0.
High-Dose,Pulsatile Erlotinib/Gefitinib for Advanced NSCLC Patients After Failure of Standard Dose EGFR-TKIs
ClinicalTrials.gov study NCT01965275. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
EMB-01 in Combination With Osimertinib in Patients With EGFR Mutant Lung Cancer
ClinicalTrials.gov study NCT05498389. IPD Sharing: NO. Countries: 2. Publications: 0.
ACE Reno, Pico Cell Matrix and Its Effect on eGFR in Chronic Kidney Diseases
ClinicalTrials.gov study NCT07187713. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of SKB264 in Combination With Osimertinib Versus Osimertinib in Patients With Epidermal Growth Factor Receptor (EGFR) Mutations, Locally Advanced or Metastatic Non-Squamous Non-Small Cell Lung
ClinicalTrials.gov study NCT06670196. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Icotinib as an Adjuvant Therapy for Patients With Stage IIA-IIIA Adenocarcinoma With EGFR Mutation
ClinicalTrials.gov study NCT02044328. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of EGFR TKIs in Patients With Rare EGFR-mutated NSCLC
ClinicalTrials.gov study NCT01775943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Trial of YH32364 in Patients With Locally Advanced or Metastatic EGFR Overexpressing Solid Tumors
ClinicalTrials.gov study NCT06975410. IPD Sharing: YES. Countries: 1. Publications: 0.
Exploring Cancer Evolution, Prognostic and Predictive Biomarkers in EGFR-mutant NSCLC
ClinicalTrials.gov study NCT05997719. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.